Metropolitan Life Insurance Company (MetLife)’s Ocugen OCGN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,957	Closed	-$10.2K	–	2498
2023 Q1	$10.2K	Sell	11,957 -997	-8%	-$1.09K	﹤0.01%	2154
2022 Q4	$16.8K	Hold	12,954	–	–	﹤0.01%	2100
2022 Q3	$23.1K	Buy	12,954 +5,184	+67%	+$12.9K	﹤0.01%	1960
2022 Q2	$17.6K	Sell	7,770 -4,350	-36%	-$10.4K	﹤0.01%	2101
2022 Q1	$40K	Sell	12,120 -36,758	-75%	-$129K	﹤0.01%	1723
2021 Q4	$222K	Buy	48,878 +5,219	+12%	+$39.4K	﹤0.01%	1957
2021 Q3	$313K	Sell	43,659 -8,240	-16%	-$60.5K	﹤0.01%	1742
2021 Q2	$417K	Buy	+51,899	New	+$438K	0.01%	1633

Other funds holding OCGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s OCGN Position: Q2 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Ocugen (OCGN) in Q2 2023, closing a stake of 11,957 shares — an estimated $10.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in OCGN in Q2 2021 and held it in 8 quarters. The position peaked at $417K in Q2 2021. 96 funds tracked by Wall St. Rank hold OCGN as of Q2 2023.

Metropolitan Life Insurance Company (MetLife) reported no remaining Ocugen position as of Q2 2023 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 11,957 Ocugen shares in Q2 2023, an estimated $10.2K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Ocugen in Q2 2021 and held it in 8 quarters.
Metropolitan Life Insurance Company (MetLife)'s Ocugen position peaked at $417K in Q2 2021.
96 funds tracked by Wall St. Rank held Ocugen as of Q2 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.